Exact Mass: 414.2631

Exact Mass Matches: 414.2631

Found 40 metabolites which its exact mass value is equals to given mass value 414.2631, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ascorbyl palmitate

2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate

C22H38O7 (414.2617)


Antioxidant.Ascorbyl palmitate is an ester formed from ascorbic acid and palmitic acid creating a fat-soluble form of vitamin C. In addition to its use as a source of vitamin C, it is also used as an antioxidant food additive (E number E304). Oral supplements of ascorbyl palmitate are less effective, due to the substance breaking down again into its components before being digested. Ascorbyl palmitate is also marketed as "vitamin C ester D020011 - Protective Agents > D016587 - Antimutagenic Agents D020011 - Protective Agents > D000975 - Antioxidants D000970 - Antineoplastic Agents Antioxidant

   

(10R,13S,17S)-17-Hydroxy-13-methyl-10-[(4-methylphenyl)methyl]-17-prop-1-ynyl-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one

(10R,13S,17S)-17-Hydroxy-13-methyl-10-[(4-methylphenyl)methyl]-17-prop-1-ynyl-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one

C29H34O2 (414.2559)


   

1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine

1-(2 (Diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine

C28H34N2O (414.2671)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

(+)-Epopromycin B

(+)-Epopromycin B

C21H38N2O6 (414.273)


   

Feigrisolide D

Feigrisolide D

C22H38O7 (414.2617)


   

MEGxm0_000218

MEGxm0_000218

C22H38O7 (414.2617)


   

3,7-dimethyl-1-<2-O-(2-methylbutyroyl)-3-O-acetyl-beta-D-xylopyranosyloxy>-6-octene|3,7-dimethyl-1-[2-O-(2-methylbutyroyl)-3-O-acetyl-beta-D-xylopyranosyloxy]-6-octene

3,7-dimethyl-1-<2-O-(2-methylbutyroyl)-3-O-acetyl-beta-D-xylopyranosyloxy>-6-octene|3,7-dimethyl-1-[2-O-(2-methylbutyroyl)-3-O-acetyl-beta-D-xylopyranosyloxy]-6-octene

C22H38O7 (414.2617)


   

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid

NCGC00180573-03!2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid

C22H38O7 (414.2617)


   

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid

C22H38O7 (414.2617)


   

tBuO-Glu(Ome)-Val-hexanoate

tBuO-Glu(Ome)-Val-hexanoate

C21H38N2O6 (414.273)


   

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid [IIN-based: Match]

NCGC00180573-03!2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]butyl]oxolan-2-yl]propanoic acid [IIN-based: Match]

C22H38O7 (414.2617)


   

Ascorbyl palmitate

L-Ascorbyl 6-palmitate

C22H38O7 (414.2617)


D020011 - Protective Agents > D016587 - Antimutagenic Agents D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant D000970 - Antineoplastic Agents

   

2-{5-[2-({2-[5-(2-Hydroxybutyl)tetrahydro-2-furanyl]propanoyl}oxy)butyl]tetrahydro-2-furanyl}propanoic acid

2-{5-[2-({2-[5-(2-Hydroxybutyl)tetrahydro-2-furanyl]propanoyl}oxy)butyl]tetrahydro-2-furanyl}propanoic acid

C22H38O7 (414.2617)


   

WE 22:3;O5

2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate

C22H38O7 (414.2617)


   

2-ethylhexyl prop-2-enoate,2-hydroxyethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

2-ethylhexyl prop-2-enoate,2-hydroxyethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C22H38O7 (414.2617)


   

[S-(R*,R*)]-4-(2-methylbutyl)phenyl 4-(2-methylbutyl)[1,1-biphenyl]-4-carboxylate

[S-(R*,R*)]-4-(2-methylbutyl)phenyl 4-(2-methylbutyl)[1,1-biphenyl]-4-carboxylate

C29H34O2 (414.2559)


   

trans,trans-3,4,5-Trifluoro-4-(4-propylbicyclohexyl-4-yl)biphenyl

trans,trans-3,4,5-Trifluoro-4-(4-propylbicyclohexyl-4-yl)biphenyl

C27H33F3 (414.2534)


   
   

Antalarmin hydrochloride

Antalarmin hydrochloride

C24H35ClN4 (414.255)


   

CID 15594425

CID 15594425

C29H34O2 (414.2559)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

1-[2-[[2-(methylamino)-1-oxopropyl]amino]-1-oxobutyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2-pyrrolidinecarboxamide

1-[2-[[2-(methylamino)-1-oxopropyl]amino]-1-oxobutyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2-pyrrolidinecarboxamide

C23H34N4O3 (414.2631)


   

(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-N-propan-2-yl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-N-propan-2-yl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C23H34N4O3 (414.2631)


   

(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-N-propan-2-yl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-N-propan-2-yl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C23H34N4O3 (414.2631)


   

[2-hydroxy-2-[(2R)-3-hydroxy-4,5-dioxooxolan-2-yl]ethyl] hexadecanoate

[2-hydroxy-2-[(2R)-3-hydroxy-4,5-dioxooxolan-2-yl]ethyl] hexadecanoate

C22H38O7 (414.2617)


   

[(2S)-2-hydroxy-2-[(2S)-3-hydroxy-4,5-dioxooxolan-2-yl]ethyl] hexadecanoate

[(2S)-2-hydroxy-2-[(2S)-3-hydroxy-4,5-dioxooxolan-2-yl]ethyl] hexadecanoate

C22H38O7 (414.2617)


   

GBR 12935

1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine

C28H34N2O (414.2671)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   
   

(2r,3r,4s,5r)-4-(acetyloxy)-2-{[(3r)-3,7-dimethyloct-6-en-1-yl]oxy}-5-hydroxyoxan-3-yl (2r)-2-methylbutanoate

(2r,3r,4s,5r)-4-(acetyloxy)-2-{[(3r)-3,7-dimethyloct-6-en-1-yl]oxy}-5-hydroxyoxan-3-yl (2r)-2-methylbutanoate

C22H38O7 (414.2617)


   

4-(acetyloxy)-2-[(3,7-dimethyloct-6-en-1-yl)oxy]-5-hydroxyoxan-3-yl 2-methylbutanoate

4-(acetyloxy)-2-[(3,7-dimethyloct-6-en-1-yl)oxy]-5-hydroxyoxan-3-yl 2-methylbutanoate

C22H38O7 (414.2617)


   

7-epi-leopersin f

NA

C22H38O7 (414.2617)


{"Ingredient_id": "HBIN013177","Ingredient_name": "7-epi-leopersin f","Alias": "NA","Ingredient_formula": "C22H38O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "12647","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(4bs,6ar,7s,10ar,10bs)-7-[(acetyloxy)methyl]-2-(carboxymethyl)-4b,7,10a-trimethyl-4ah,5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-4a-yl

(4bs,6ar,7s,10ar,10bs)-7-[(acetyloxy)methyl]-2-(carboxymethyl)-4b,7,10a-trimethyl-4ah,5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-4a-yl

C25H36NO4 (414.2644)


   

2-{5-[2-({2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyl}oxy)butyl]oxolan-2-yl}propanoic acid

2-{5-[2-({2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyl}oxy)butyl]oxolan-2-yl}propanoic acid

C22H38O7 (414.2617)


   

(2s)-1-[(2s,5r)-5-[(2r)-1-ethoxy-1-oxopropan-2-yl]oxolan-2-yl]propan-2-yl (2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoate

(2s)-1-[(2s,5r)-5-[(2r)-1-ethoxy-1-oxopropan-2-yl]oxolan-2-yl]propan-2-yl (2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoate

C22H38O7 (414.2617)


   

(1s,2s,5s,8r,9r,12s,14r)-12-ethyl-8-hydroxy-5-[(2r)-2-hydroxybutyl]-2,9-dimethyl-4,11,17-trioxabicyclo[12.2.1]heptadecane-3,10-dione

(1s,2s,5s,8r,9r,12s,14r)-12-ethyl-8-hydroxy-5-[(2r)-2-hydroxybutyl]-2,9-dimethyl-4,11,17-trioxabicyclo[12.2.1]heptadecane-3,10-dione

C22H38O7 (414.2617)


   

(4br,7s,10ar)-7-[(acetyloxy)methyl]-2-(carboxymethyl)-4b,7,10a-trimethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

(4br,7s,10ar)-7-[(acetyloxy)methyl]-2-(carboxymethyl)-4b,7,10a-trimethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

[C25H36NO4]+ (414.2644)


   

n-[(1s)-2-hydroxy-1-{[(2s)-1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}ethyl]-7-methyloctanimidic acid

n-[(1s)-2-hydroxy-1-{[(2s)-1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}ethyl]-7-methyloctanimidic acid

C21H38N2O6 (414.273)


   

ethyl 2-{5-[2-({2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyl}oxy)propyl]oxolan-2-yl}propanoate

ethyl 2-{5-[2-({2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyl}oxy)propyl]oxolan-2-yl}propanoate

C22H38O7 (414.2617)


   

(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxybutyl]oxolan-2-yl]propanoyl]oxy}butyl]oxolan-2-yl]propanoic acid

(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxybutyl]oxolan-2-yl]propanoyl]oxy}butyl]oxolan-2-yl]propanoic acid

C22H38O7 (414.2617)


   

12-ethyl-8-hydroxy-5-(2-hydroxybutyl)-2,9-dimethyl-4,11,17-trioxabicyclo[12.2.1]heptadecane-3,10-dione

12-ethyl-8-hydroxy-5-(2-hydroxybutyl)-2,9-dimethyl-4,11,17-trioxabicyclo[12.2.1]heptadecane-3,10-dione

C22H38O7 (414.2617)


   

n-[(1s)-2-hydroxy-1-{[(2s)-1-[(2r)-2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}ethyl]-7-methyloctanimidic acid

n-[(1s)-2-hydroxy-1-{[(2s)-1-[(2r)-2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}ethyl]-7-methyloctanimidic acid

C21H38N2O6 (414.273)